Cargando…
Lipi Guben decoction in treating diarrheal irritable bowel syndrome: A study protocol for a randomized controlled trial
BACKGROUND: Irritable bowel syndrome (IBS) is a common functional bowel disorder. The global incidence of IBS is as high as 9% to 23%, accounting for about 50% of outpatients in gastroenterology, and the new case detection rate is 0.2% every year. IBS has become a global gastrointestinal functional...
Autores principales: | Yang, Hongmei, Liu, Xin, Peng, Wei, Chen, Rong, Chen, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837987/ https://www.ncbi.nlm.nih.gov/pubmed/33545956 http://dx.doi.org/10.1097/MD.0000000000023887 |
Ejemplares similares
-
Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial
por: Ji, Lijiang, et al.
Publicado: (2022) -
Herbal medicine for irritable bowel syndrome: An overview of systematic reviews protocol
por: Jun, Hyejin, et al.
Publicado: (2021) -
Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial
por: Shi, Sheng-Mei, et al.
Publicado: (2019) -
Maxingshigan decoction for treating COVID-19: A protocol for systematic review and meta analysis
por: Shao, Guoliang, et al.
Publicado: (2020) -
Effectiveness of acupuncture for anxiety and depression in irritable bowel syndrome: A protocol for systematic review and meta-analysis
por: Li, Huaiyu, et al.
Publicado: (2021)